 Participants will be recruited from an existing protocol at St. Jude SJLIFE, NCT00760656. Complete neuropathic evaluations are obtained as part of SJLIFE, and the information will be shared for use in the SJLPSC study. A one-time blood draw will be obtained, and peripheral blood mononuclear cells PBMCs will be isolated for eventual creation of induced pluripotent stem cells iPSC that will be differentiated into human neurons. These human neurons will allow the investigators to functionally validate and further interrogate CEP72 genetic variants or variants in other genes that are associated with persistent or acute vincristine neuropathy using a state of the art cellular model of human neurons. Furthermore, creating neurons from patients at the extremes highly sensitive to vincristine-induced neuropathy and matched controls allows the study of differences at baseline and after treatment with vincristine. 